Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer

The concept of immunogenic cell death (ICD) has emerged as a cornerstone of therapy-induced anti-tumor immunity. To this end, the following chemotherapies were evaluated for their ability to induce ICD in non-small cell lung cancer (NSCLC) cell lines: docetaxel, carboplatin, cisplatin, oxaliplatin a...

Descripción completa

Detalles Bibliográficos
Autores principales: Flieswasser, Tal, Van Loenhout, Jinthe, Freire Boullosa, Laurie, Van den Eynde, Astrid, De Waele, Jorrit, Van Audenaerde, Jonas, Lardon, Filip, Smits, Evelien, Pauwels, Patrick, Jacobs, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349161/
https://www.ncbi.nlm.nih.gov/pubmed/32560232
http://dx.doi.org/10.3390/cells9061474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349161/
https://www.ncbi.nlm.nih.gov/pubmed/32560232
http://dx.doi.org/10.3390/cells9061474

Ejemplares similares